MX2010004232A - Compuesto de indolina de pirimidilo. - Google Patents
Compuesto de indolina de pirimidilo.Info
- Publication number
- MX2010004232A MX2010004232A MX2010004232A MX2010004232A MX2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A MX 2010004232 A MX2010004232 A MX 2010004232A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- indoline compound
- pyrimidyl
- pyrimidyl indoline
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Se describe un compuesto de indolina de pirimidilo que tiene una estructura diferente a la de un compuesto utilizado como un ingrediente activo para un agente hiperglucémico oral convencional, y que tiene una excelente actividad hipergiucémica. Se describe en forma específica un compuesto representado por la fórmula general (I) o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007268937 | 2007-10-16 | ||
PCT/JP2008/068607 WO2009051119A1 (ja) | 2007-10-16 | 2008-10-15 | ピリミジルインドリン化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004232A true MX2010004232A (es) | 2010-09-30 |
Family
ID=40567381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004232A MX2010004232A (es) | 2007-10-16 | 2008-10-15 | Compuesto de indolina de pirimidilo. |
Country Status (16)
Country | Link |
---|---|
US (1) | US8232287B2 (es) |
EP (1) | EP2210886B1 (es) |
JP (1) | JP5317354B2 (es) |
KR (1) | KR101536021B1 (es) |
CN (1) | CN101896481B (es) |
AU (1) | AU2008312948C1 (es) |
BR (1) | BRPI0818338A2 (es) |
CA (1) | CA2710182C (es) |
IL (1) | IL205057A0 (es) |
MX (1) | MX2010004232A (es) |
MY (1) | MY151295A (es) |
NZ (1) | NZ585284A (es) |
RU (1) | RU2464269C2 (es) |
TW (1) | TWI421074B (es) |
WO (1) | WO2009051119A1 (es) |
ZA (1) | ZA201002552B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2399914A4 (en) * | 2009-02-18 | 2012-08-29 | Takeda Pharmaceutical | FUSED HETEROCYCLIC RING CONNECTION |
EP2427448A1 (en) * | 2009-05-08 | 2012-03-14 | Pfizer Inc. | Gpr 119 modulators |
CA2759843A1 (en) * | 2009-05-08 | 2010-11-10 | Pfizer Inc. | Gpr 119 modulators |
AR077214A1 (es) * | 2009-06-24 | 2011-08-10 | Neurocrine Biosciences Inc | Heterociclos nitrogenados y composiciones farmaceuticas que los contienen |
JP5467151B2 (ja) | 2009-06-24 | 2014-04-09 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規化合物、医薬組成物及びそれに関する方法 |
WO2011017296A1 (en) * | 2009-08-04 | 2011-02-10 | Schering Corporation | 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
EP2474540A4 (en) * | 2009-08-31 | 2013-03-13 | Nippon Chemiphar Co | GPR119 AGONIST |
WO2011061679A1 (en) * | 2009-11-23 | 2011-05-26 | Pfizer Inc. | Imidazo-pyrazoles as gpr119 inhibitors |
JP5833570B2 (ja) * | 2010-01-20 | 2015-12-16 | サノフイ | アルキル−複素環カルバメート誘導体、この調製およびこの治療的適用 |
FR2955580A1 (fr) * | 2010-01-28 | 2011-07-29 | Sanofi Aventis | Derives de carbamate d'alkyl-heterocycles, leur preparation et leur application en therapeutique |
TW201204733A (en) | 2010-06-25 | 2012-02-01 | Kowa Co | Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
WO2012025811A1 (en) | 2010-08-23 | 2012-03-01 | Lupin Limited | Indolylpyrimidines as modulators of gpr119 |
DK2625177T3 (en) | 2010-10-08 | 2015-10-12 | Cadila Healthcare Ltd | New GPR 119 agonists |
CA2818050A1 (en) * | 2010-11-26 | 2012-05-31 | Lupin Limited | Bicyclic gpr119 modulators |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
US9233958B2 (en) | 2012-01-18 | 2016-01-12 | Daiichi Sankyo Company, Limited | Substituted phenylazole derivatives |
US20160060235A1 (en) * | 2013-03-29 | 2016-03-03 | National University Corporation Kumamoto University | Therapeutic Agent for Type 2 Diabetes |
CA3125900A1 (en) * | 2019-01-08 | 2020-07-16 | Kyorin Pharmaceutical Co., Ltd. | 15-pgdh inhibitor |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW406075B (en) * | 1994-12-13 | 2000-09-21 | Upjohn Co | Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds |
CZ20021703A3 (cs) | 1999-11-30 | 2003-06-18 | Pfizer Products Inc. | 2,4-Diaminopyrimidinové sloučeniny užitečné jako imunosupresiva |
US7101869B2 (en) | 1999-11-30 | 2006-09-05 | Pfizer Inc. | 2,4-diaminopyrimidine compounds useful as immunosuppressants |
SI1529043T1 (sl) | 2002-06-19 | 2006-12-31 | Biovitrum Ab | Postopek za pripravo 2-metil piperazinskih derivatov |
US7078419B2 (en) * | 2003-03-10 | 2006-07-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Cytokine inhibitors |
AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
UA86943C2 (ru) * | 2003-07-11 | 2009-06-10 | Арена Фармасьютикалз, Инк. | Тризамещенные производные арилов и гетероарилов как модуляторы метаболизма и профилактика и лечение связанных с ними нарушений |
FR2866884B1 (fr) | 2004-02-26 | 2007-08-31 | Sanofi Synthelabo | Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application en therapeutique |
DE602005011279D1 (de) * | 2004-06-04 | 2009-01-08 | Arena Pharm Inc | Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen |
MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
AU2006264649A1 (en) | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
WO2008008887A2 (en) * | 2006-07-13 | 2008-01-17 | Smithkline Beecham Corporation | Gpr119 agonists for treating metabolic disorders |
-
2008
- 2008-10-15 EP EP08840535.2A patent/EP2210886B1/en not_active Not-in-force
- 2008-10-15 KR KR1020107008031A patent/KR101536021B1/ko not_active IP Right Cessation
- 2008-10-15 JP JP2009538098A patent/JP5317354B2/ja not_active Expired - Fee Related
- 2008-10-15 AU AU2008312948A patent/AU2008312948C1/en not_active Ceased
- 2008-10-15 TW TW097139503A patent/TWI421074B/zh not_active IP Right Cessation
- 2008-10-15 RU RU2010119487/04A patent/RU2464269C2/ru not_active IP Right Cessation
- 2008-10-15 MX MX2010004232A patent/MX2010004232A/es active IP Right Grant
- 2008-10-15 WO PCT/JP2008/068607 patent/WO2009051119A1/ja active Application Filing
- 2008-10-15 MY MYPI20101724 patent/MY151295A/en unknown
- 2008-10-15 BR BRPI0818338 patent/BRPI0818338A2/pt not_active IP Right Cessation
- 2008-10-15 CN CN200880122006.9A patent/CN101896481B/zh not_active Expired - Fee Related
- 2008-10-15 CA CA2710182A patent/CA2710182C/en not_active Expired - Fee Related
- 2008-10-15 US US12/738,200 patent/US8232287B2/en not_active Expired - Fee Related
- 2008-10-15 NZ NZ585284A patent/NZ585284A/en not_active IP Right Cessation
-
2010
- 2010-04-12 ZA ZA2010/02552A patent/ZA201002552B/en unknown
- 2010-04-13 IL IL205057A patent/IL205057A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2210886A4 (en) | 2011-08-17 |
RU2010119487A (ru) | 2011-11-27 |
JP5317354B2 (ja) | 2013-10-16 |
EP2210886B1 (en) | 2015-09-23 |
IL205057A0 (en) | 2010-11-30 |
KR20100071068A (ko) | 2010-06-28 |
CN101896481A (zh) | 2010-11-24 |
BRPI0818338A2 (pt) | 2015-04-22 |
AU2008312948A1 (en) | 2009-04-23 |
WO2009051119A1 (ja) | 2009-04-23 |
US20100292259A1 (en) | 2010-11-18 |
EP2210886A1 (en) | 2010-07-28 |
JPWO2009051119A1 (ja) | 2011-03-03 |
CN101896481B (zh) | 2014-04-30 |
TWI421074B (zh) | 2014-01-01 |
RU2464269C2 (ru) | 2012-10-20 |
ZA201002552B (en) | 2011-10-26 |
CA2710182C (en) | 2012-08-14 |
US8232287B2 (en) | 2012-07-31 |
CA2710182A1 (en) | 2009-04-23 |
NZ585284A (en) | 2011-03-31 |
KR101536021B1 (ko) | 2015-07-10 |
AU2008312948C1 (en) | 2012-08-09 |
AU2008312948B2 (en) | 2012-03-01 |
MY151295A (en) | 2014-04-30 |
TW200922588A (en) | 2009-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010004232A (es) | Compuesto de indolina de pirimidilo. | |
TW200728307A (en) | Novel spirochromanone derivatives | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
WO2010026436A3 (en) | 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders | |
MX2007004699A (es) | Derivados de indol y bencimidazol. | |
TW200612958A (en) | Substituted imidazole derivatives | |
WO2007117465A3 (en) | Indazole compounds | |
UA105229C2 (uk) | Фармацевтичний склад | |
IN2012DN02465A (es) | ||
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
RS54123B1 (en) | THERAPEUTIC COMBINATION CONTAINING DOLUTEGRAVIR, ABACAVIR AND LAMIVUDINE | |
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
WO2007084728A3 (en) | 2-imino-benzimidazoles | |
MX2009008540A (es) | Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
MY147188A (en) | Substituted imidazole compounds as ksp inhibitors | |
MX2012002528A (es) | Agente terapeutico para trastornos del estado de animo. | |
TN2013000257A1 (en) | Immunosuppressant formulations | |
AU2010321366A8 (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
TN2012000105A1 (en) | Spirolactam derivatives and uses of same | |
WO2009096667A3 (ko) | 신규한 퀴나졸린-2,4-디온 유도체 및 이를 함유하는 뇌신경질환 예방 및 치료용 의약 조성물 | |
TN2012000093A1 (en) | Therapeutic agent for anxiety disorders | |
MX342824B (es) | Nuevos compuestos de triazol iii. | |
MY160963A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |